Mitochondrial dysfunction has been a hallmark of cancer. However, whether it has a causative role awaits to be elucidated. Here, using an animal model derived from inactivation of SUV3, a mitochondrial helicase, we demonstrated that mSuv3 þ /À mice harbored increased mitochondrial DNA (mtDNA) mutations and decreased mtDNA copy numbers, leading to tumor development in various sites and shortened lifespan. These phenotypes were transmitted maternally, indicating the etiological role of the mitochondria. Importantly, reduced SUV3 expression was observed in human breast tumor specimens compared with corresponding normal tissues in two independent cohorts. These results demonstrated for the first time that maintaining mtDNA integrity by SUV3 helicase is critical for cancer suppression.
INTRODUCTION
The mitochondria generate most of the cellular ATP and reactive oxygen species, regulate cellular calcium levels and initiate cell death through the activation of the mitochondrial permeability transition pore. 1, 2 Each mammalian cell contains hundreds of mitochondria and each mitochondrion contains multiple copies of circular mitochondrial DNA (mtDNA) molecules. The mtDNA encodes 13 polypeptides central to the mitochondrial energyproduction system, oxidative phosphorylation (OXPHOS), as well as the rRNAs and tRNAs necessary for mitochondrial protein synthesis. The mtDNA is replicated from two origins, one for the G-rich heavy strand located in the control region and the other for the C-rich light strand located 2/3 of the way around the mtDNA. 3 Cells have developed extensive systems for maintaining mitochondrial integrity, and disturbance of mitochondrial homeostasis can lead to multiple diseases. 2 In general, the mtDNA has a higher mutation rate than the nuclear DNA (nDNA) genes. The accumulation of mtDNA mutations has not only been linked to ageing 2,4 --6 but also to cancer progression. 7, 8 However, the causative roles of mitochondrial genome integrity in ageing and cancer remain to be substantiated.
SUV3 is a nuclear encoded ATP-dependent DNA/RNA helicase that primarily localizes to the mitochondrion. In Saccharomyces cerevisiae, Suv3 is a key component of the mitochondrial RNA degradosome besides the Dss1 exoribonuclease. 9 --11 Deficiency of SUV3 is associated with group-I intron accumulation 10 and changes in the stability and processing of several mitochondrial RNAs. 11 Yeast cells carrying null or mutant Suv3 genes gradually lose their capacity to grow on non-fermentable carbon sources and acquire a petite phenotype. 12, 13 In human cells, depletion of SUV3 by small interfering RNA leads to pleiotropic effects including decreased mtDNA copy number, a shift in mitochondrial morphology from tubular to granular and eventual senescence or cell death. 14 Although the yeast Suv3 and mammalian SUV3 genes share high sequence homology, salient differences between the two species, such as the absence of Dss1 in human mitochondria and the lack of introns in mammalian mtDNA, raise the question of whether the yeast and mammalian SUV3 serve analogous mitochondrial functions.
To clarify the function of mammalian SUV3, we generated a mouse Suv3 (mSuv3)-knockout mouse. The homozygous mSuv3-knockout mice were embryonically lethal, suggesting an essential role of mSuv3 in embyronic development. Heterozygous (mSuv3 þ /À) animals, on the other side, had a shortened lifespan, reduced fecundity and increased tumor incidence. More intriguingly, such effects were maternally transmitted, as only the mother but not the father, harboring the mutated mSuv3 gene, could transmit the defects to subsequent generations regardless of the progenies' nDNA genotype. The progenies of mSuv3 þ /À females showed elevated mtDNA mutation loads and reduced mtDNA copy numbers. These data suggest that SUV3 is a tumor-suppressor gene and that inactivation of one allele leads to destablization of mtDNA integrity, causing the observed detrimental effects in mice. Based on the fact that mSuv3 þ /À mice showed an increased tumor incidence, we quantitated the SUV3 mRNA level in two independent cohorts of human breast cancer specimens. We found that SUV3 mRNA expression was significantly reduced in tumor samples compared with adjacent normal tissue in a panel of breast cancer specimens. Taken together, our data indicated that reduction of SUV3 expression level, either by genetic ablation of one allele of Suv3 in mice or by other unknown mechanisms in human, could lead to destablization of mtDNA and promotes tumorigenesis, further supporting the notion that SUV3 is a potential human tumor suppressor that functions in a haploinsufficient manner.
RESULTS

Targeted disruption of the mSuv3 locus leads to embryonic lethality
To test if deficiency in mammalian SUV3 would lead to detrimental effect in animal as a whole as it does in yeast, we inactivated the mSuv3 gene in embryonic stem (ES) cells to generate a knockout mouse model for SUV3. The mSuv3 gene was obtained by screening a 129/Sv-derived genomic library using the human SUV3 cDNA as a probe. The targeting vector, mSuv3-KO, was constructed by inserting an anti-parallel pgkneopA cassette into the mSuv3 location corresponding to codon 684 of the human SUV3, which rendered the SUV3 mRNA unstable and blocked SUV3 expression. The successfully targeted ES cells were used to generate chimeric mice, which ultimately resulted in germ-line transmission of the knockout gene ( Figure 1a ). An approximate 50% reduction in SUV3 protein level was observed in mSuv3 heterozygous (mSuv3 þ /À) mouse embryonic fibroblasts (MEFs) when compared with the wild-type MEF (Figure 1b ). There was no detectable truncated SUV3 protein in heterozygous MEF, further indicating that the knockout allele is a null depletion of SUV3.
The mSuv3 þ /À mice were interbred and the genotypes of the offspring were determined at 10 days of age using PCR analysis of toe DNA. Out of the 74 animals screened, 52 were heterozygous (mSuv3 þ /À) and 22 were wild type (mSuv3 þ / þ ) with no homozygous mutant (mSuv3À/À), suggesting that the mSuv3À/À embryos are nonviable, which is consistent as previously described. 15 To pinpoint the time of death, pregnant females of E5.0--E11.5 from mSuv3 þ /À intercrosses were killed and the fetuses were subjected to genotyping. At both E9.5 and E11.5, no mSuv3À/À embryos were found, instead, many resorbed embryos were present. Hence, the mSuv3 À/À embryos died by E9.5 (Figure 1c ).
To further characterize the developmental defects, decidual swellings from mSuv3 þ /À intercrossed females were obtained between embryonic E5.0 and E8.5 and examined histologically following staining with hematoxylin/eosin. As shown in Figure 1d , both mSuv3 þ / þ and mSuv3 þ /À embryos exhibited normal growth, depicted by the elongation of the egg cylinder and formation of embryonic and extra-embryonic ectoderm, as well as distinct proamniotic cavities. In contrast, mSuv3À/À embryos presented abnormalities following implantation (E5.0 --E5.5), as they were smaller and failed to form the typical egg cylinders. By the time when mSuv3 þ / þ embryos underwent gastrulation (E7.5 --E8.0), the growth of mSuv3À/À embryos were remarkably delayed. By E8.5, the mSuv3À/À embryos started to degenerate and were resorbed, consistent with aforementioned genotyping results ( Figure 1c ).
Shortened lifespan of mSuv3 heterozygotes at different intercross generations
To monitor the effect of mSuv3 mutation over generations, we carried out a systematic study on intercrossed mice. The first generation (F1) of heterozygous mSuv3 þ /À mice obtained by crossing the chimeric founder male with C57/BL6 female had normal lifespan comparable to the mSuv3 þ / þ wild-type mice ( Figure 2A ). However, the second generation (F2) of mSuv3 þ /À heterozygotes derived from intercrossing F1 heterozygotes had significantly shortened lifespan, which was aggravated in subsequent intercrosses of mSuv3 þ /À mice for the third and fourth generations (F3 and F4, respectively). In addition, some of the intercross heterozygous (mSuv3 þ /À) mice showed signs 4) and two candidate recombinant clones (mSuv3-ko 5 (lanes 2 and 5) and mSuv3 ko 149 (lanes 3 and 6)) were digested with SalI --BamHI and probed with either probe A or the neo probe. An additional fragment of the expected size of 11.6 kb was found in each of the recombinant clones. (b) Western blot analysis of SUV3 protein level. Whole-cell lysate of MEFs of wild type (lane 1) and heterozygote (lane 2) were separated by SDS --PAGE and probed with an antibody against SUV3. p48 was used as a loading control. (c) Genotypes of offspring from heterozygous mSuv3 þ /À mice intercross. Pregnant females of mSuv3 þ /À intercrosses were killed and the fetuses were examined at different gestation times from E3.5 --E11.5 days. (d) Developmental abnormalities of mSuv3 mutant embryos. Histological analysis was performed on embryo sections of wild-type and mSuv3À/À conceptuses. The uteri of mSuv3 þ /À females were dissected between 5.0 and 8.0 days after intercross and 4 mm sections were prepared. All uterine decidua were sectioned transversely and labeled as described. 48 The mesometrial to anti-mesometrial axis is from left to right. a, amnion; c, chorion; eer, extraembryonic region; ep, epiblast; pac, proamniotic cavity and ve, viceral endoderm. Bar, 100 mm. of premature ageing including kyphosis (data not shown). These data suggested that inactivating one allele of mSuv3 leads to reduced longevity over generations.
SUV3 acts as a tumor suppressor with haploinsufficiency Through pathological examinations, we found high incidence of solid tumors in mSuv3 þ /À mice. On autopsy, 90% of the mSuv3 þ /À intercross mice exhibited a broad spectrum of tumor types, including lymphoma and carcinoma ( Figures 2B and C) . It was noted that about two-thirds of the mSuv3 þ /À mice succumbed to lymphoma. The mSuv3 þ /À tumor incidence was substantially higher than the 30% incidence seen in the mSuv3 þ / þ mice from similar genetic crosses. To determine if the tumors in mSuv3 þ /À mice acquired a second mutation in the wild-type mSuv3 allele, we isolated tumor cells by microdissections ( Figure 2D ) and analyzed the wild-type mSuv3 locus using PCR. As shown in Figure 2E , all of the tumor samples retained the wild-type mSuv3 allele. This was further confirmed by immunostaining with anti-SUV3 antibodies as the majority of the tumor samples were SUV3 positive ( Figure 2F ). These data combined indicated that loss of 50% of SUV3 protein, by genetic ablation of one mSuv3 allele, is sufficient to predispose the mice for tumorigenesis.
Mitochondrial function is a dominant determinant for mSuv3 inheritance In the course of analyzing the F3 intercrossed mSuv3 þ /À mice, we found that even the mSuv3 þ / þ mice, the mice carrying two wild-type mSuv3 alleles, showed shortened lifespan and were prone to tumors at a comparable level to that of their mSuv3 þ /À littermates ( Figures 2B and 3a ). This observation suggested that the reduced lifespan and increased tumor incidence were not simple consequences of the nDNA genotype. Because SUV3 has been shown to be important in maintaining mitochondrial homeostasis, 14 we investigated if a maternal factor might be contributing to the progressively declined lifespan and increased tumor incidence in mSuv3 þ / þ mice of F3. Accordingly, we crossed F3 mSuv3 þ /À males with C57/BL6 wild-type females. As shown in Figure 3b , the average lifespan of the heterozygous offspring with wild-type mitochondria inherited from their mothers was 782 days, which was comparable to that of the F1 cohort (801 days). In contrast, when F3 mSuv3 þ /À females were crossed with C57/BL6 males, the average lifespan of the their heterozygote offsprings carrying mitochondria from their mSuv3 þ /À mothers was 559 days, simlar to the lifespan of the F3 mice ( Figure 3b ). Moreover, the mSuv3 þ / þ wild-type offsprings generated from crossing F3 mSuv3 þ /À females with C57/BL6 males also had reduced average lifespan of 631 days (Figure 3c ), which was significantly shorter than that of the heterozygous mice (mSuv3 þ /À) with mitochondria derived from wild-type females (782 days), but not statistically different from the average lifespan (560 days) of offsprings from mSuv3 þ /À females (P ¼ 0.37) ( Figure 3b ). Autopsies performed on mSuv3 þ / þ offsprings derived from mSuv3 þ /À female by crossing with C57/BL6 male revealed the presence of tumor nodules, predominately lymphoma and pituitary adenoma, with nearly complete penetrance ( Figure 3c ). Apparently, the status of mitochondria on the maternal side determines the outcome of the lifespan and tumor incidence in their offsprings, rather than their own nDNA genotype in terms of mSuv3.
Similarly, the reproductive performance of the mSuv3 þ /À strain also depends on the status of mitochondria function. The litter size and number of viable pups of the F1 and F2 mSuv3 þ /À intercrossed mice were comparable to that of the wild-type mice (6 --8 pups) (Figures 4a and b ). However, the reproductive output (Figure 4c ). Severe reduction in reproductive performance was also found in the mSuv3 þ / þ F4 female ( Figure 4d ). Besides, these mSuv3 þ / þ ; mt-msuv3 þ /À pups that did survive were found to be sterile at 3 --5 months of age, further suggesting the dominance of mitochondrial status over nuclear genotype. In the subsequent part of this communication, we designated the mitochondria derived from an mSuv3 þ /À female as (mt-msuv3 þ /À) and that from an mSuv3 þ / þ female as (mt-msuv3 þ / þ ).
Increased mutation load and reduced mtDNA copy number correlate with high tumor incidence and shortened lifespan To test whether mtDNA serves as the key factor that determines the maternally transmitted defects, we generated four genotype cohorts of mice by crossing mSuv3 þ /À male or female mice with C57/BL6 mice: Figure 5a ). Then, mtDNA mutation load and mtDNA copy number of these four cohorts of mice were analyzed. A DNA region surrounding the L-strand replication origin (nucleotide 4418 --6409) was sequenced to assess mtDNA mutation load. As shown in Figure 5a , the levels of new mtDNA mutations were increased about threefolds in Cohorts B, C and D compared with agematched Cohort A or C57/BL6 mice. This data suggested that the deficiency of SUV3 increases mtDNA mutation load. Once the mtDNA mutations have been predisposed, they are stable and transmitted through the female germ line, which may not be affected by nuclear genotype.
To further characterize the effects of the mSuv3 þ /À genotype on mtDNA metabolism, we analyzed the mtDNA to nDNA copy number ratio on the spleens of 15-month-old mice, quantified by real time PCR using mtDNA 12S rRNA and nDNA 18S rRNA primers ( Figure 5b ). The mtDNA copy number was markedly reduced in Cohorts B, C and D relative to Cohort A. Hence, both the mSuv3 þ /À nuclear genotype and the mSuv3 þ /À femaletransmitted mtDNA contributed to the reduction in the mtDNA copy number. Hence, both the nuclear mSuv3 mutation and the maternally inherited defective mitochondria did contribute to the overall reduction in the mtDNA copy number in the mice.
Because these mtDNA aberrations may reduce mitochondrial activities, we then examined the biochemical activities of mitochondrial OXPHOS complexes I, II þ III and IV, each containing one or more mtDNA-encoded subunits. Mitochondria isolated from the brains of 10-month-old animals in Cohorts B, C and D showed significantly reduced OXPHOS complex activities than those of Cohort A (Figure 5c ). Therefore, the increased mtDNA mutation rate and reduced mtDNA copy number indeed deteriorated mitochondrial energy production.
To further validate the contribution of mitochondrial aberration to the aforementioned phenotypes observed in mSuv3 þ /À mice, we crossed mSuv3 þ /À with C57/BL6 for two additional generations to obtain sufficient progenies for each cohort. Consistent with our earlier observation, the average lifespan of the F3 of Cohorts C (489 days) and D (534 days) were significantly shorter than that of Cohorts A (732 days) and B (688 days) (Po0.0001) ( Figure 5d ). Similar to the observation shown in Figure 3c , we found that Cohorts B, C and D had tumor incidences approaching 100%, which were significantly higher than the 50% tumor incidence seen in Cohort A. These data further indicated that the reduced lifespan and increased tumor incidence correlate with the mtDNA aberration, rather than the mSuv3 nDNA genotype, supporting the hypothesis that the defective mtDNA is a key factor to the observed phenotypes.
MEFs derived from mice with aberrant mtDNA exibit impaired proliferation capability To determine if this mitochondrial dysfunction would impede cellular function, we generated MEFs from the four cohorts (genotyping shown in Figure 6a ) and measured their proliferation capacity following the 3T3 protocol. 16 By this protocol, the Cohort A MEF cells doubled in number every three days for eight passages, after which the cells were arrested in crisis state and the 3-day cell counts were comparable to the inoculation levels. In contrast, the cells from Cohorts B, C and D did not have an initial proliferative phase but immediately showed low proliferation potential (Figure 6b ), suggesting these fibroblasts might already enter senescence when initially explanted. To determine if the reduced proliferative capacity of the Cohorts B, C and D could be correlated to the loss of mtDNA integrity, we assessed the mtDNA copy numbers of the four cell cohorts at the fourth passage. The mtDNA copy numbers of the MEFs from Cohorts B, C and D were apparently less than half of that of Cohort A (Figure 6c ).
Wt X Parent
Wt X Collectively, our data suggested that the mSuv3 þ /À nDNA mutation and maternally transmitted mtDNA abnormalities lead to impaired MEF proliferation reminiscent of premature cellular senescence.
Breast tumor cells express low amounts of SUV3 compared with nonmalignant cells As mentioned above, SUV3 is a highly conserved protein during evolution. Given the substantial stimulation in tumor incidence after inactivation of only one allele of mSuv3 in mice, it is likely that deficiency of SUV3 may also have a similar role in human tumorigenesis. To validate this, we compared the expression of Suv3 mRNA within a cohort of 18 pairs of breast tumor and adjacent normal tissues. As shown in Figure 7a , 11 tumor specimens contained significantly reduced Suv3 mRNA. In another cohort with 19 normal tissues and 45 breast tumor specimens, the expression of Suv3 mRNA in tumors was also significantly lower than that in normal tissues (Figure 7b ). These data provided us the first clinical evidence to support the notion that reduction of SUV3 expression may participate in human tumorigenesis, which can be resulted from the loss of mtDNA integrity.
DISCUSSION
In this communication, we demonstrated that inactivating one allele of mSuv3 in mice shortens the lifespan and predisposes the animals to tumor formation with 90% penetrance. Heterozygote offsprings derived from crossing mSuv3 þ /À male with C57/BL6 female live as long as wild-type mice, whereas those from crossing mSuv3 þ /À female with C57/BL6 male exhibit shortened lifespan. Moreover, shortened lifespan, reduced fecundity and multiple tumor formations are seen in mSuv3 þ / þ mice with mitochondria derived from mSuv3 þ /À mother, suggesting that the disease phenotypes follow patterns of maternal mitochondrial inheritance. Findings such as higher mutation rates and reduced mtDNA copy numbers are observed in the offsprings with mitochondria derived from mSuv3 þ /À mother, suggesting that SUV3 is a novel tumor suppressor that functions through maintainance of the mitochondrial genome integrity. Genomic instability is a hallmark of human cancer. Many of the tumor-suppressor genes identified so far are critical for maintaining genome stability. For example, the prototypic RB gene has been shown to be essential in monitoring chromosomesegregation fidelity and cell-cycle entrance. 17 p53 and BRCA1/2 participate in maintaining genome stability by regulating the DNA-damage repair response pathways in addition to other functions. 18, 19 For this group of tumor-suppressor genes, both alleles are inactivated in tumor cells, but reintroduction of one wildtype allele can suppress tumor growth by inducing cell-cycle arrest or tumor-cell apoptosis. 20 On the other hand, another group of tumor-susceptibility genes, such as Mismatch repair (MMR) genes, Werner syndrome (WNS) gene and Bloom's syndrome (BLM) gene, directly participate in DNA repair. 21, 22 Defects in MMR genes can lead to mutations in the type-II TGF-beta receptor, causing hereditary non-polyposis colorectal cancer. 23 However, different from the previous group of tumor-suppressor genes like RB, reintroducing MMR gene back to hereditary non-polyposis colorectal cancer cells cannot suppress the tumor progression. The other two genes in this group, WNS and BLM, both encode RecQ helicases, and inactivating both copies of the genes results in premature ageing and cancer. 22 Interestingly, inactivation of one allele of SUV3 helicase in our mouse model appears to trigger an increase of mtDNA mutations and a reduction in the mtDNA copy numbers, an analogy of mitochondrial genomic instability, leading to increased tumor incidences. These mutated and dysfunctional mitochondria are sufficient to enhance tumor formation even when both copies of wild-type mSuv3 were present. The mSuv3-knockout mice described here provides a unique genetic model to study the mitochondrial genomic instability in cancer predisposition.
It is noted that the protein level of SUV3 in mouse is critical for maintaining mitochondria genomic stability because the expression from just one copy of wild-type allele is insufficient (Figure 1 ). This haploinsufficiency principle appears to be the common mechanism seen in many other transgenic mouse tumor models that inactivates both copies of critical genes, such as AML1, 24 p27KIP1, 25 Lkb1, 26 CtIP, 27 Smad4 28 and RINT1, 29 usually leads to cell death and embryonic lethality, while inactivation of one allele prediposes the animal to tumorigenesis. More intriguingly, tumor cells derived from these animals frequently keep the remaining wild-type allele, instead of losing it as in the case of RB or p53. If such principle also applies to human cancer, reduction of mtDNA as well as SUV3 protein should be observed in at least some human cancers. Indeed, when we surveyed two cohorts of human breast tumor specimens, the expression of SUV3 mRNA in tumors is also significantly lower than in normal tissues. These results implicate that a reduction of SUV3 expression may be involved in the tumorigenesis in a portion of human cancers. Thus, any genetic or epigenetic event that reduces the expression of SUV3 may contribute to mitochondrial genomic instability and promote tumor formation.
How does inactivating one allele of mSuv3 leads to mitochondrial genomic instability? SUV3 is known as a component of the mitochondrial RNA degradosome for decades. 10, 12, 13 In yeast, we Figure 4 . The fecundity is significantly reduced in the F3 of mSuv3 heterozygous mice. Designated female mice (a, b, c and d) were housed together with C57/BL6 male for 8 weeks; the number of pups of each delivery and litter were recorded to determine the fecundity of female mice.
SUV3 insufficiency in mice causes mitochondrial genome instability P-L Chen et al and others have demonstrated that inactivation of the ySuv3 gene leads to respiratory deficiency and compromized mtDNA integrity. 12, 30 In mammalian system, we also observed an accumulation of truncated mitochondrial RNA transcripts and reduction in mtDNA copy number in SUV3-knockdown cells. 14 In fact, in addition to its role in RNA degradation, 31 mammalian SUV3 has been shown to participate in several DNA processes, including unwinding double-stranded DNA substrates 32 and associating with purified mitochondrial nucleoids. 33 These potential biochemical activities of SUV3 suggest that SUV3 may be involved in preventing mtDNA mutagenesis and/or facilitating replication. Consistent with this notion, we have demonstrated that SUV3 is associated with actively replicating mitochondrial nucleoids in yeast, 30 although a direct biochemical link remains to be demonstrated.
Recently, an increase of mtDNA mutations has been observed in mice carrying a mutant POLG, a mtDNA mutator. 34 --36 However, the mtDNA copy numbers stayed at the same level as wild-type animals, 37 suggesting a potentially different mechanism from the role of SUV3 in maintaining mitochondrial genomic stability. It is noted that a small amount of SUV3 localizes to nucleus, where it interacts with BLM helicase. 15 However, the precise function of such interaction remains to be established. Although we cannot completely rule out the potential nuclear role of SUV3 that might have an impact on these phenotypes, our backcross data (Figure 3 ) clearly indicated the maternal effect of SUV3. Regardless of the mechanism, mitochondrial dysfunctions resulted from SUV3 insufficiency clearly enhance tumorigenesis, strongly supporting the notion that mitochondrial integrity is important during development and progression of cancers. 2, 38 It has been reported that mtDNA mutations are prevalent in colon cancer. 39, 40 Therefore, loss of mtDNA integrity may be a general feature for cancer, as the accumulation of mtDNA mutations may increase mitochondrial reactive oxygen species production, which is a potent mitogen. 41, 42 SUV3 as a tumor suppressor operating on mitochondria is conforming with the growing data that both tumor suppressors and oncogenes can target to mitochondrial functions. For example, SIRT3, a newly identified tumor suppressor, is nuclear-encoded but localized to mitochondria. 43 In addition, deregulation of metabolic enzymes, such as NADP þ -dependent isocitrate dehydrogenase enzymes (IDH1 and IDH2) have been linked to human glioma. 44, 45 Thus, this new paradigm offers a potential mechanism for a group of human cancers with maternal inheritance otherwise recognized as sporadic cancer.
MATERIALS AND METHODS
Construction of mSuv3 targeting vector
The Mus musculus Suv3 (mSuv3) gene was isolated by screening a mouse 129/Sv genomic library (kindly provided by Dr Tom Doetschman, University of Cincinnati) using a 2.4-kb fragment of human SUV3 cDNA as the probe. 
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Lifespan comparison: A:B P=0.399 C:D P=0.180 A:C P<0.0001 A:D P<0.0001 B:C P<0.0001 B:D P=0.0007 Figure 5 . Defective mitochondria inherited from mSuv3 þ /À female leads to increased tumorigenicity and reduced lifespan regardless of nuclear genotype. The offspring from the cross of mSuv3 þ /À female with C57/BL6 male and mSuv3 þ /À male with C57/BL6 female were designated as four cohorts: Cohort A (mSuv3 þ / þ ; mt-msuv3 þ / þ ); Cohort B, (mSuv3 þ /À; mt-msuv3 þ / þ ); Cohort C, (mSuv3 þ / þ ; mt-msuv3 þ /À); and Cohort D (mSuv3 þ /À; mt-msuv3 þ /À). (a) The region surrounding the mtDNA L-strand origin was sequenced and mtDNA mutation rates were calculated from brain samples collected from 10-month-old mice in each cohort. (b) The mtDNA to nDNA copy number ratio was determined from seven to eight spleens of 15-month-old mice of each cohort by quantitative real-time PCR using mitochondrial 12S rDNA and nuclear 18S rDNA gene primers (Student's t-test was used to assess Pvalue). (c) Enzyme activities of OXPHOS complexes containing mtDNA encoded subunits, complexes I, II þ III and IV, assessed on brain mitochondria of 10-month-old animals from each cohort. (d) Lifespan and tumor incidence of the offspring (the F3) derived from mSuv3 þ /À backcross with C57/BL6 mice. (Student's t-test was used to assess P-value).
subcloned into the pBluescript SK vector (Stratagene, Santa Clara, CA, USA), yielding a pBg5 plasmid. The internal HindIII site, corresponding to amino-acid residue 684 of human SUV3, was restricted and converted to SalI by ligation with a SalI linker. A pgkneopA cassette 46 in antisense orientation was inserted into the engineered SalI site and the resulting plasmid was designated as pmSuv3-neo. The BglII fragment of mSuv3-neo was then subcloned into a p2TK vector 47 to produce the final targeting vector designated as mSuv3-KO.
Selection of ES clones
SalI-linearized mSuv3-KO-targeting vector was electroporated into an E14.1. ES cells and selected in medium containing G418 (250 mg/ml) and 2 0 -fluoro-2 0 -deoxy-1-b-D-arabinofuranosyl-5-iodo-uracil (1 mM). DNA extracted from the resistant ES cell clones was digested with BamHI --SalI and analyzed using Southern blotting. A 0.8-kb BamHI --BglII fragment, designated as probe A, corresponding to a region at 5 0 end of the genomic sequence in the targeting vector, was used to identify bands of 10 kb and 11.6 kb, which correspond to germ line wild-type mSuv3 and the homologous recombinant allele, respectively. An additional DNA probe corresponding to a fragment in the neo gene was also used to identify the neo-containing restriction fragment.
Embryo collection, PCR genotyping and histology of embryos from mSuv3 heterozygote intercrosses Mice heterozygous (F1) for the mSuv3 mutant allele were mated and toes from F2 progeny were cut for genotype analysis. Embryos from timed pregnancies were dissected from maternal decidua. For embryos 4E9.5, the visceral yolk sac was collected and genotyped using PCR. 48 For E4.5 --E8.5 embryos, uterine embryos were excized and fixed in 4% paraformaldehyde. After embedded in paraffin, the embryos were sectioned and stained with Mayer's hematoxylin and eosin. Genotypings were performed on the microdissected cells from stained slides. E3.5 blastocysts were flushed from maternal uterus and genotyped using PCR. The targeted allele, a 236-bp product within the pgkneopA cassette, was assayed using primers: forward: 5 0 -TGATATTGCTGAAGAGCTTGGCGGC-3 0 ; reverse: 5 0 -TGGGAGTGGCACCTTCCAGGGTCAA-3 0 . The wild-type allele, 149-bp product within the targeted exon of the mouse mSuv3 gene, was assessed using the primers: forward: 5 0 -TCCAAGAAGGCGTGCACAACATCAC-3 0 ; reverse: 5 0 -ACTTTTGGTGCCACGTGTCCTTCTC-3 0 .
Breeding of mSuv3 heterozygous mice
The F1 heterozygous mSuv3 þ /À mice were derived from crossing two chimeric mice with C57/BL6 mice, generating a hybrid between the 129SvJ and C57/BL6 inbred backgrounds. The F1 mSuv3 þ /À mice were then interbred to generate mice with two mSuv3 genotypes (mSuv3 þ / þ and mSuv3 þ /À). The F2 mSuv3 þ /À mice were interbred to generate F3 mSuv3 þ / þ and mSuv3 þ /À mice. Similarly, F3 mSuv3 þ /À mice were interbred to generate F4 mSuv3 þ / þ and mSuv3 þ /À mice. Because the female F3 and F4 mSuv3 þ /À mice were not very fertile, the mSuv3knockout allele was maintained by crossing male F4 mSuv3 þ /À mice with C57/BL6 females. The F1 --F4 mice, which were on a mixed C57/BL6 and 129SvJ backgrounds, were analyzed ( Figure 2 ).
Breeding of mSuv3 heterozygous mice into C57/BL6 predominant background
The F3 heterozygous mSuv3 þ /À mice were crossed with C57BL/6 wildtype mice and the progeny were analyzed (Figure 3b ). Subsequent crosses for two additional generations were analyzed in Figure 5d .
Fecundity determination
Female mSuv3 þ /À or mSuv3 þ / þ mice were housed together with C57/ BL6 male starting at 8 weeks of age. The birth date and number of pups of each delivery were recorded. Pups were weaned at 21 days. Mitochondrial enzymatic assays OXPHOS enzyme analysis 51 was performed on isolated mitochondria, which were lyzed by three cycles of freeze-and-thaw in liquid N 2 and 37 1C water bath, respectively. OXPHOS complexes I, II þ III and IV were assayed immediately using spectrophotometric assays. Complex I activity was measured as the rotenone-sensitive NADH oxidation rate at 340 nm. Complex II þ III activity was measured as the cytochrome c reduction rate at 550 nm and complex IV activity as the reduced cytochrome c oxidation rate at 550 nm. Citrate synthase activity was used as a standard to normalize for mitochondria amount.
Histology and immunohistochemistry
Isolation and culturing of MEFs
Primary MEF cultures were isolated from individual E12.5 embryos obtained from crossing heterozygous male and female mSuv3 þ /À mice with C57/BL6 mice. The MEFs were expanded for one passage and genotyped using PCR analysis. Complete Dulbecco's modified Eagle's medium with high glucose containing 10% fetal bovine serum, 25 mM/ml sodium pyruvate, 100 units/ml penicillin and 100 mg of streptomycin was used for culturing MEF cells. For the proliferation assays, the MEFs were propagated according to the 3T3 protocol, 16 in which the cells were harvested, counted and 3 Â 10 5 cells were seeded into a new 60-mm dish every 3 days. Cell lines were propagated until all the MEF cultures entered crisis.
Western blot analysis
Proteins were separated by SDS --PAGE, blotted to Immobilon-P membranes (Millipore, Billerica, MA, USA) and probed with antibodies against p48 (GeneTex, Irvine, CA, USA) or SUV3, using a mouse anti-human SUV3 polyclonal antibody generated against the GST-SUV3 fusion protein (amino-acids 1 --122).
Quantitative real-time PCR assay
Quantitative real-time PCR was performed using Fast SYBR-Green master mix according to the manufacturer's instruction and analyzed on a
StepOnePlus Real-Time PCR system (Applied Biosystems, Carlsbad, CA, USA). Human SUV3 mRNA levels were calculated according to the relative DCt method using b-actin mRNA as an internal control. Primers used are: human b-actin: ACTB forward: 5 0 -ATCTGGCACCACACCTTCTACA-3 0 ; ACTB reverse: 5 0 -TCACCGGAGTCCATCACGAT-3 0 ; human SUV3: SUV3 forward: 5 0 -ATCAGGGAGCCAGTCACGAT-3 0 ; and SUV3 reverse: 5 0 -GCTGGGTGGCT CAGTAGCTT-3 0 .
Statistical analysis
Except for the quantifications of specific immunoblots, mouse-tumorigenesis assay and cell-growth assay, all data are presented as means ± s.d. Student's t-test was used to compare control and treatment groups. Asterisk (*) indicates statistical significance with P-value o0.05. 
